Method for separating carbamazepine and its related substances through liquid chromatography

一种卡马西平、液相色谱的技术,应用在液相色谱法分离卡马西平及有关物质领域,能够解决说明方法灵敏度不够、杂质E信噪比不能满足验证的条件、杂质E灵敏度低等问题

Active Publication Date: 2018-06-15
山东则正医药技术有限公司
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0044] In specific experiments, the inventor found that the detection of carbamazepine impurities according to the liquid phase conditions of the Chinese Pharmacopoeia had the following defects: the signal-to-noise ratio of each impurity in carbamazepine was relatively low at 9-10 μg, and the risk was compared when confirming the method Large, especially low sensitivity of impurity E
When the impurity E is 2 μg / mL, the signal-to-noise ratio is only 1.67, indicating that the sensitivity of the method is not enough
When Waters e2695-2489 is used, the signal-to-noise ratio of the impurity peak does not change much. When the impurity concentration is 1 μg / mL, the signal-to-noise ratio of impurity E cannot meet the verification conditions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example 1

[0104] Experimental Example 1: Verification of Chromatographic Conditions in Pharmacopoeia

[0105] According to the chromatographic conditions stipulated in the Chinese Pharmacopoeia, a system adaptability experiment was carried out on carbamazepine, and the carbamazepine sample used was produced by our company with batch number 2017021303. The specific chromatographic conditions are as follows:

[0106] (1) Chromatographic conditions

[0107]

[0108] (2) Sample preparation

[0109]

[0110]

[0111] (3) See the results figure 1 . The separation of carbamazepine and impurity A, impurity B, impurity C, impurity D and impurity E is as follows.

[0112] name

keep time

area

Number of theoretical plates

Separation

S / N (Signal to Noise Ratio)

Impurity B

9.153

439898

3861

58.06

Impurity A

12.379

162994

3594

4.70

15.93

carbamazepine

14.193

8501116

3802

2.13

725.00

Impuri...

Embodiment 1

[0132] Embodiment 1: the exploratory test of carbamazepine related substance detection condition

[0133] 1. First, change the mobile phase system. There is tetrahydrofuran in the mobile phase system, which has absorption at low wavelengths, which may cover up the impurity peaks, and adopt the acetonitrile-water gradient elution method. The new chromatographic conditions are as follows:

[0134] (1) Chromatographic conditions

[0135]

[0136] (2) See the attached chromatogram for the results Figure 5 . Carbamazepine and the separation of impurities are as follows:

[0137]

[0138] (3) Conclusion

[0139] The concentration of each impurity in carbamazepine was about 9 μg / mL, one impurity in carbamazepine did not appear as a peak, and the other impurities were well separated. Reason analysis: In addition to removing tetrahydrofuran from the mobile phase, triethylamine was removed at the same time, and the impurity of carbamazepine contains N, so there is no peak. ...

Embodiment 2

[0200] Embodiment 2 Destructive test

[0201] 1 Acid, alkali and oxidation damage (sample group: 2017032801)

[0202] 1.1 Undestroyed API

[0203] Take 75 mg of carbamazepine raw material, accurately weigh it, put it in a 50 ml measuring bottle, add 25 ml of methanol to dissolve, ultrasonically dissolve, add water to dilute to the mark, shake well, and obtain. Measure 5.00ml of the solution in a 50ml volumetric flask, add 22ml of methanol, dilute with water to the mark, and shake well to obtain.

[0204] see attached results Figure 17 :

[0205] name

keep time

peak name

Purity angle

Purity Threshold

area

area%

Separation

s / n

1

21.338

main peak

0.232

0.345

52876503

100

12862.92

[0206] 1.2 Acid Destruction

[0207] Acid-base blank: Pipette 5.00ml of 1mol / L hydrochloric acid solution and sodium hydroxide solution into a 50ml volumetric flask, add 25ml of methanol solution, dilute with water to t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for separating carbamazepine and its related substances through liquid chromatography. The method is high performance liquid chromatography. The mobile phase system and the sample introduction volume are changed to improve the impurity detection sensitivity, especially the impurity E detection sensitivity, in order to effectively control the quality of carbamazepine.

Description

technical field [0001] The invention belongs to the technical field of medical detection, and in particular relates to a method for separating carbamazepine and related substances by liquid chromatography. Background technique [0002] Carbamazepine is a common psychotropic drug. It is mainly used clinically for: epilepsy: partial seizures: complex partial seizures, simple partial seizures and secondary generalized seizures. Generalized seizures: tonic, clonic, tonic-clonic seizures. Trigeminal neuralgia and glossopharyngeal neuralgia attack, also used as a long-term prophylactic drug after trigeminal neuralgia relief. It can also be used for tabes dorsalis and multiple sclerosis. The aliases of carbamazepine are: carbamazepine, carbamoyl benzodiazepine, carbamazepine, chadianning, chadianning, Delido, Delido, Fen Leptosin, formylbenzoate, carbamazine, carbamazepine, chemical name 5H-dibenzo[b, f]azepine-5-carboxamide, CAS No. 298-46-4. [0003] During the preparation an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02
CPCG01N30/02G01N2030/027
Inventor 于风平贺敦伟梁左冲
Owner 山东则正医药技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products